Showing results (531-540 of 5,674) with videos related to

Sort By:
Pageof 568
The Oncologist|October 22, 2011
The effect of Oncotype DX recurrence score on treatment recommendations for patients with estrogen receptor-positive early stage breast cancer and correlation with estimation of recurrence risk by breast cancer specialistsJennifer E Joh, Nicole N Esposito, John V Kiluk, et al.
The Oncologist|October 22, 2011
Cetuximab plus FOLFIRINOX (ERBIRINOX) as first-line treatment for unresectable metastatic colorectal cancer: a phase II trialEric Assenat, Francoise Desseigne, Simon Thezenas, et al.
The Oncologist|September 3, 2011
The significance of early alpha-fetoprotein level changes in predicting clinical and survival benefits in advanced hepatocellular carcinoma patients receiving sorafenibThomas Yau, T J Yao, Pierre Chan, et al.
The Oncologist|February 16, 2012
Outpatient use of low molecular weight heparin monotherapy for first-line treatment of venous thromboembolism in advanced cancerThomas Delate, Daniel M Witt, Debra Ritzwoller, et al.
The Oncologist|February 16, 2012
Targeted therapy in the management of advanced gastric cancer: are we making progress in the era of personalized medicine?Hilda Wong, Thomas Yau
The Oncologist|January 24, 2012
Should the denosumab metastasis prevention trial change practice for men with nonmetastatic prostate cancer?Philip J Saylor, M Dror Michaelson
The Oncologist|January 12, 2012
Curative strategies for liver metastases from colorectal cancer: a reviewNicholas Zdenkowski, Stanley Chen, Andre van der Westhuizen, et al.
The Oncologist|January 12, 2012
Sarcomatoid renal cell carcinoma: a comprehensive review of the biology and current treatment strategiesBrian Shuch, Gennady Bratslavsky, W Marston Linehan, et al.
The Oncologist|April 6, 2012
Accumulating evidence for a drug-drug interaction between methotrexate and proton pump inhibitorsShewit Bezabeh, Ann Corken Mackey, Paul Kluetz, et al.
The Oncologist|January 28, 2012
Phase II study of gonadotropin-releasing hormone analog for ovarian function preservation in hematopoietic stem cell transplantation patientsYee Chung Cheng, Mariko Takagi, Andrea Milbourne, et al.
Pageof 568